CIHR dedicated funding for European programs in key research areas
November 2021

The Canadian Institutes of Health Research continues its long-standing collaboration with the European Commission by supporting an additional joint transnational call in 2021 and anticipates four (4) more in 2022.

The Canadian dedicated funding will support the involvement of Canadian researchers in multinational research consortia in the following areas: neurodegenerative diseases, rare diseases, and antimicrobial resistance.

CIHR engagement in the EU Framework Programme is predominantly through public-to-public (P2P) partnerships involving EU member states, Third Countries (e.g. Canada), Associated Countries, and the European Commission.

Between 2010-11 and 2020-21, CIHR has participated in 57 joint transnational calls under P2Ps and has funded the Canadian component of 213 multinational teams, invested over $46 million and leveraged $167 million through these programs. CIHR dedicated an additional $5.3 million to four (4) joint transnational calls in 2021.

Joint Transnational Calls

Website links to the joint transnational calls are added as they become available.

2021 JPND Call: 2021 Working Groups “The impact of COVID-19 on Neurodegenerative Diseases research”
JPND is an international component of the CIHR Dementia Research Strategy

Description: To establish expert Working Groups to discuss research strategies concerning the impact of COVID-19 on the development and progression of neurodegenerative disease.

Funding: $78,000 from CIHR Institute of Aging and $78,000 from Public Health Agency of Canada, for a total of up to $156,000, to support the Canadian component of up to two (2) transnational working groups over one year. Maximum amount per grant is $78,000 over one (1) year.

Deadline: December 14, 2021 (full proposal).

EJP Rare Diseases Call: “Development of new analytic tools and pathways to accelerate diagnosis and diagnostic monitoring of rare diseases”
EJP-RD is an international component of the CIHR Personalized Health Initiative

Description: To enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project focused on a group of rare diseases or a single rare disease and based on complementarities and sharing of expertise, with expected impact to use the results in the future for benefit of patients.

Funding: $1.35M from CIHR Institute of Genetics and $450,000 from Ataxia Canada and $450,000 from Fonds de recherche du Québec – Santé (FRQ-S), for a total of up to $2.25M, to support the Canadian component of up to five (5) transnational teams, over three (3) years. Maximum amount per grant is $450,000 over three (3) years.

Deadline: February 16, 2022 (pre-proposal); June 15, 2022 (full proposal).

2022 JPND Call: “Understanding the mechanism of non-pharmacological interventions"
JPND is an international component of the CIHR Dementia Research Strategy

Description: To establish research projects aimed at understanding the biomedical, psychological and/or social mechanisms of non-pharmaceutical interventions.

Funding: $666,000 from CIHR Institute of Aging to support the Canadian component of up to two (2) transnational teams, over four (4) years. Maximum amount per grant is $333,000, over four (4) years.

Deadline: March 1, 2022 (pre-proposal); June 28, 2022 (full proposal).

JPIAMR Call: “Disrupting Drug Resistance Using Innovative Design”
JPIAMR is an international component of the CIHR Antimicrobial Resistance Initiative

Description: To establish research projects supporting research and therapeutic interventions based on the optimization of drug delivery or drug combinations to treat bacterial or fungal infections in One Health settings.

Funding: $900,000 from CIHR to support the Canadian component of up to two (2) transnational teams, over three (3) years. Maximum amount per grant $450,000 over three (3) years.

Deadline: March 8, 2022 (pre-proposal); July 5, 2022 (full proposal).

CoEN Call: “International CoEN Initiative in Neurodegeneration”
CoEN is an international component of the CIHR Dementia Research Strategy

Description: To establish research projects addressing the need for innovative research to underpin new approaches to therapeutic intervention.

Funding: $666,000 from CIHR Institute of Aging to support up to two (2) grants over three (3) years. Maximum amount per grant is up to $333,333, over three (3) years.

Deadline: May 10, 2022 (full proposal)

Contact information

For general inquiries please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
support-soutien@cihr-irsc.gc.ca

Disclaimer

The information contained in this pre-announcement is subject to change and does not commit CIHR or partners to the requirements outlined in this version. The final funding opportunity will be published by CIHR in the Funding Opportunity Database in ResearchNet.

Date modified: